Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Alkermes (ALKS) over the last 13 years, with Q4 2024 value amounting to $2.2 million.

  • Alkermes' Gains from Sales and Divestitures fell 1372.68% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year decrease of 1372.68%. This contributed to the annual value of $2.2 million for FY2024, which is 1372.68% down from last year.
  • As of Q4 2024, Alkermes' Gains from Sales and Divestitures stood at $2.2 million, which was down 1372.68% from $2.6 million recorded in Q4 2023.
  • Over the past 5 years, Alkermes' Gains from Sales and Divestitures peaked at $2.6 million during Q4 2023, and registered a low of $1.1 million during Q4 2020.
  • Its 5-year average for Gains from Sales and Divestitures is $2.0 million, with a median of $2.1 million in 2022.
  • As far as peak fluctuations go, Alkermes' Gains from Sales and Divestitures surged by 7215.67% in 2021, and later tumbled by 1372.68% in 2024.
  • Quarter analysis of 5 years shows Alkermes' Gains from Sales and Divestitures stood at $1.1 million in 2020, then skyrocketed by 72.16% to $1.9 million in 2021, then rose by 8.63% to $2.1 million in 2022, then rose by 26.39% to $2.6 million in 2023, then dropped by 13.73% to $2.2 million in 2024.
  • Its last three reported values are $2.2 million in Q4 2024, $2.6 million for Q4 2023, and $2.1 million during Q4 2022.